| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8369 | 
      | Human Intestinal Absorption | HIA+ | 0.9968 | 
      | Caco-2 Permeability | Caco2+ | 0.5576 | 
      | P-glycoprotein Substrate | Substrate | 0.6532 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.7971 | 
                                                     | Inhibitor | 0.5926 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7189 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7705 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8277 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8863 | 
      | CYP450 3A4 Substrate | Substrate | 0.5527 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.9055 | 
      | CYP450 2C9 Inhibitor | Inhibitor | 0.8278 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.7167 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.9153 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.7687 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9416 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9070 | 
                                                                    | Non-inhibitor | 0.9034 | 
      | AMES Toxicity | AMES toxic | 0.9226 | 
      | Carcinogens | Non-carcinogens | 0.9347 | 
      | Fish Toxicity | High FHMT | 0.9954 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9928 | 
      | Honey Bee Toxicity | High HBT | 0.9007 | 
      | Biodegradation | Not ready biodegradable | 0.6754 | 
      | Acute Oral Toxicity | III | 0.6372 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5953 |